Small Scale Bioreactors Market is Expected to be Flourished by the Rising Adoption in Early Stage Drug Development
Small Scale
Bioreactors Market
Bioreactors are vessels used for cultivation of cells, tissues or organs
with precise control of environmental conditions such as temperature, pH and
oxygen concentration. Small scale bioreactors are commonly used during research
and development activities to grow cells and tissues. These bioreactors have a
capacity of up to 50 liters and are widely used in drug discovery, cell line
development and screening applications. Growing biopharmaceutical industry has
led to increasing adoption of small scale bioreactors for cell culture studies
during early stage drug development. This has fueled the global demand for
small scale bioreactors. Cultivation of cells in the benchtop bioreactors
enables flexible research compared to large scale production thus finding
extensive use in biologics production.
The global small scale bioreactors market is estimated to be valued at
US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Dynamics:
The rising adoption of small scale bioreactors in early stage drug development
is expected to drive the growth of the market over the forecast period. Growing
focus on biopharmaceuticals has increased R&D investment in developing
novel biologics. Small scale bioreactors enable researchers to evaluate cell
culture conditions and optimization during the initial development stage. This
has resulted in growing demand for benchtop bioreactors with reduced operation
costs and higher production flexibility compared to large scale systems.
Additionally, technological advancements have led to the introduction of smart
bioreactors integrated with sensors, software and analytics. These systems
provide real time data on process parameters and quality attributes thus
improving process optimization. Growing preference for single use technologies
is another factor expected to propel the small scale bioreactors market growth
during the forecast period.
Segment Analysis
The global small scale bioreactors market is dominated by stirred tank
bioreactors segment owing to their wide usage in research and development
applications. The stirred tank bioreactors provide homogeneous culture
conditions suitable for large scale production of therapeutic proteins,
antibodies and other biomolecules which makes it popular among
biopharmaceutical manufacturers.
Pest Analysis
Political: Government support and regulation for biopharmaceutical research is
driving demand for small scale bioreactors. Various nations are supporting
development of local biotech industry.
Economic: Rising healthcare expenditure and growth of biologics market are
fueling investments in biomanufacturing which requires small scale bioreactors
for research and process development.
Social: Increasing incidence of chronic diseases is generating demand for
therapeutic biomolecules produced using small scale bioreactors.
Technological: Advancements in design of bioreactors with sensors, online
monitoring capabilities and single use technologies are supporting their usage
in process development and optimization.
Key Takeaways
The global Small
Scale Bioreactors Market Demand is expected to witness high growth over
the forecast period supported by increasing investments in biopharmaceutical
R&D. The global small scale bioreactors market is estimated to be valued at
US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the
forecast period 2023 to 2030.
Regional analysis
The North America region dominates the global small scale bioreactors market
holding around 35% share. This is attributed to presence of major pharma
companies and robust biotech research in the US. Growing biologics drug
pipeline and rising investments to develop novel formulations at small scale
are fueling demand.
Key players
Key players operating in the small scale bioreactors market are Merck KGaA,
Danaher Corporation, Getinge AB, Sartorius AG,Thermo Fisher Scientific Inc.,
Lonza Group, Eppendorf AG, Miltenyi Biotec. These players focus on developing
advanced single use bioreactors and systems for cell culture process
development and production of biologics at small scale.
For more details on the report,
Read- https://www.ukwebwire.com/small-scale-bioreactors-market-share-analysis/
Comments
Post a Comment